Work

An update of a phase I/II study of the VEGF receptor tyrosine kinase inhibitor vatalanib and gemcitabine in patients with advanced pancreatic cancer

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.15571

Authors: T. Kuo, E. C. Cabebe, A. Koong, J. A. Norton, P. L. Kunz, J. M. Ford, H. L. Kaiser, J. Rogers, B. I. Sikic, G. A. Fisher

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249405846

Cites:

Cited by: 6

Related to: 10